Opioid Prescribing Patterns and Patient Outcomes by Prescriber Type in the Oregon Prescription Drug Monitoring Program

被引:17
|
作者
Fink, Patrick B. [1 ]
Deyo, Richard A. [1 ,3 ,4 ,5 ]
Hallvik, Sara E. [2 ]
Hildebran, Christi [2 ]
机构
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] HealthInsight Oregon, Portland, OR USA
[3] Dept Family Med, Portland, OR USA
[4] Dept Med, Portland, OR USA
[5] Oregon Inst Occupat Hlth, Portland, OR USA
关键词
Opioids; Opioid Overdose; Prescription Drug Monitoring Programs; Clinical Practice Patterns; UNITED-STATES; PAIN; RISK;
D O I
10.1093/pm/pnx283
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objective. Prescription drug monitoring programs (PDMPs) were created to facilitate responsible use of controlled substances. In Oregon, physicians, physician's assistants (MDs/DOs/PAs), dentists, nurse practitioners (NPs), and naturopathic physicians (NDs) may prescribe opioids, but differences in prescribing practices, patient mix, and patient outcomes among prescriber types have not been characterized. Methods. De-identified Oregon PDMP data from October 2011 through October 2014 were linked with vital records and a statewide hospital discharge registry. The disciplines of registered prescribers were identified by board affiliations. Prescription profiles associated with opioid overdose risk were tabulated for patients with at least one registered prescriber. Opioid-related hospitalizations and deaths were identified using ICD-9 and ICD-10 codes. Results. There were 5,935 prescribers registered during the study period. Patients of NPs or NDs received more high-risk opioid prescriptions than patients of MDs/DOs/PAs. For example, they received greater proportions of high-dose prescriptions (NP 12.9%, ND 15%, MD/DO/PA 11.1%), and had greater opioid-related hospitalization (NP 1.7%, ND 3.1%, MD/DO/PA 1.2%; P < 0.005 for all). However, patients of NPs or NDs were also more likely to have four or more prescribers (NP 45.3%, ND 58.5%, MD/DO/PA 27.1%), and most of their patients' high-risk opioid prescriptions came from prescribers in other disciplines. Conclusions. Our analysis suggests significant differences in opioid prescription profiles and opioid-related hospitalization and mortality among patients receiving opioid prescriptions from nurse practitioners, naturopathic physicians, or medical clinicians in Oregon. However, these differences appear largely due to differences in patient mix between provider types rather than discipline-specific prescribing practices.
引用
收藏
页码:2481 / 2486
页数:6
相关论文
共 50 条
  • [1] The effect of a statewide prescription drug monitoring program on opioid prescribing patterns
    Rubin, Samuel J.
    Wang, Judy J.
    Nodoushani, Ariana Y.
    Yarlagadda, Bharat B.
    Wulu, Jacqueline A.
    Edwards, Heather A.
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2022, 43 (01)
  • [2] Effect of a Prescription Drug Monitoring Program on Emergency Department Opioid Prescribing
    Gupta, Rahul
    Boehmer, Sue
    Giampetro, David
    Gupta, Anuj
    DeFlitch, Christopher J.
    WESTERN JOURNAL OF EMERGENCY MEDICINE, 2021, 22 (03) : 756 - 762
  • [3] Leveraging the Prescription Drug Monitoring Program to Curb Opioid Prescribing in Arkansas
    Hayes, Corey J.
    Goree, Johnathan
    Turpin, Jamie
    Ortiz, Haley
    Smith, G. Richard
    Gokarakonda, Srinivasa B.
    Hyde, Carrie
    Cucciare, Michael A.
    JOURNAL OF PREVENTION, 2022, 43 (03): : 337 - 357
  • [4] Leveraging the Prescription Drug Monitoring Program to Curb Opioid Prescribing in Arkansas
    Corey J. Hayes
    Johnathan Goree
    Jamie Turpin
    Haley Ortiz
    G. Richard Smith
    Srinivasa B. Gokarakonda
    Carrie Hyde
    Michael A. Cucciare
    Journal of Prevention, 2022, 43 : 337 - 357
  • [5] The Effect of Prescription Drug Monitoring Program Electronic Medical Record Integration on Prescription Drug Monitoring Program Utilization and Opioid Prescribing
    Weiner, S. G.
    Kobayashi, K.
    Reynolds, J.
    Kelly, R.
    Chan, K.
    Wakeman, S.
    Reddy, P.
    Young, L.
    ANNALS OF EMERGENCY MEDICINE, 2019, 74 (04) : S51 - S51
  • [6] Association of Prescription Drug Monitoring Program Use With Opioid Prescribing and Health Outcomes: A Comparison of Program Users and Nonusers
    Deyo, Richard A.
    Hallvik, Sara E.
    Hildebran, Christi
    Marino, Miguel
    Springer, Rachel
    Irvine, Jessica M.
    O'Kane, Nicole
    Van Otterloo, Joshua
    Wright, Dagan A.
    Leichtling, Gillian
    Millet, Lisa M.
    Carson, Jody
    Wakeland, Wayne
    McCarty, Dennis
    JOURNAL OF PAIN, 2018, 19 (02): : 166 - 177
  • [7] Effect of Payor-Mandated Review of Prescription Drug Monitoring Program on Opioid Prescriber Rates
    Schumann, Samuel O., III
    Zhang, Jingwen
    McCauley, Jenna L.
    Heidari, Khosrow
    Ball, Sarah J.
    SOUTHERN MEDICAL JOURNAL, 2020, 113 (09) : 415 - 417
  • [8] Integrated Prescription Drug Monitoring Program for Opioid Prescribing at a Children's Hospital
    Wang, George Sam
    Bajaj, Lalit
    Poppy, Christopher
    Valuck, Robert
    CLINICAL PEDIATRICS, 2022, 61 (07) : 465 - 468
  • [9] Variations in prescription drug monitoring program use by prescriber specialty
    Sun, Benjamin C.
    Lupulescu-Mann, Nicoleta
    Charlesworth, Christina J.
    Kim, Hyunjee
    Hartung, Daniel M.
    Deyo, Richard A.
    McConnell, K. John
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2018, 94 : 35 - 40
  • [10] Evaluation of Opioid Prescribing Habits Based on Analysis of a State Prescription Drug Monitoring Program
    Alexander, John C.
    Silge, Julia
    Jones, Stephanie
    Joshi, Girish P.
    PAIN PHYSICIAN, 2019, 22 (05) : E425 - E433